A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/ emtricitabine in HIV-1-infected patients with virological suppression

  1. Martínez, E.
  2. Arranz, J.A.
  3. Podzamczer, D.
  4. Loncá, M.
  5. Sanz, J.
  6. Barragán, P.
  7. Ribera, E.
  8. Knobel, H.
  9. Roca, V.
  10. Gutiérrez, F.
  11. Blanco, J.L.
  12. Mallolas, J.
  13. Llibre, J.M.
  14. Clotet, B.
  15. Dalmau, D.
  16. Segura, F.
  17. Arribas, J.R.
  18. Cosín, J.
  19. Barrufet, P.
  20. Casas, E.
  21. Ferrer, E.
  22. Curran, A.
  23. González, A.
  24. Pich, J.
  25. Cruceta, A.
  26. Arnaiz, J.A.
  27. Miró, J.M.
  28. Gatell, J.M.
  29. Erakutsi egile guztiak +
Aldizkaria:
Journal of Acquired Immune Deficiency Syndromes

ISSN: 1525-4135

Argitalpen urtea: 2009

Alea: 51

Zenbakia: 3

Orrialdeak: 290-297

Mota: Artikulua

DOI: 10.1097/QAI.0B013E3181AA12D5 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak